Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1988-08-19
1991-02-26
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
128654, 128653, G01N 2400, A61B 600
Patent
active
049960415
ABSTRACT:
A diagnostic imaging agent is provided for use in conjunction with a magnetic resonance imaging system for the imaging of spacial oxygen distribution in tissue. The imaging agent is comprised of a complex of oxygen-17, a biologically acceptable liquid carrier, such as a perfluorinated compound, and an emulsifying agent, and wherein the agent has an average particle size of less than about 0.6 microns, and an ionic composition essentially equal to that of blood. Useful information can be obtained, and in certain instances, therapy administered, by a non-envasive imaging technique relative to tissue perfusion by .sup.19 F-NMR (imaging of .sup.19 F) and oxygen utilization by .sup.1 H-NMR (imaging of H.sub.2.sup.17 O as a metabolite).
REFERENCES:
patent: 4586511 (1986-05-01), Clark, Jr.
patent: 4775522 (1988-10-01), Clark, Jr.
Arai Toshiyuki
Gupte Pradeep M.
Lasker Sigmund E.
Friedman Stanley J.
Henley III Raymond J.
LandOfFree
Method for introducing oxygen-17 into tissue for imaging in a ma does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for introducing oxygen-17 into tissue for imaging in a ma, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for introducing oxygen-17 into tissue for imaging in a ma will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-293103